Healthcare provider profile · identity verified

Ibrahim Mohammed Rizqui, M.D,

Internal Medicine · TOWSON, MD · NPI 1386908374

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	564	97
Eliquis	Apixaban	464	55
Gabapentin	Gabapentin	289	51
Metoprolol Tartrate	Metoprolol Tartrate	284	53
Levothyroxine Sodium	Levothyroxine Sodium	266	39
Furosemide	Furosemide	257	61
Mirtazapine	Mirtazapine	251	51
Tamsulosin Hcl	Tamsulosin Hcl	249	41
Amlodipine Besylate	Amlodipine Besylate	212	43
Pantoprazole Sodium	Pantoprazole Sodium	176	42
Potassium Chloride	Potassium Chloride	169	37
Sertraline Hcl	Sertraline Hcl	166	30
Quetiapine Fumarate	Quetiapine Fumarate	163	33
Xarelto	Rivaroxaban	151	suppressed
Losartan Potassium	Losartan Potassium	150	29
Levetiracetam	Levetiracetam	146	21
Jardiance	Empagliflozin	145	22
Trazodone Hcl	Trazodone Hcl	127	26
Entresto	Sacubitril/Valsartan	126	12
Ivermectin	Ivermectin	112	57
Famotidine	Famotidine	111	26
Lisinopril	Lisinopril	107	26
Lidocaine	Lidocaine	106	23
Clopidogrel	Clopidogrel Bisulfate	102	15
Lactulose	Lactulose	101	35
Metoprolol Succinate	Metoprolol Succinate	95	24
Nifedipine Er	Nifedipine	92	22
Trulicity	Dulaglutide	88	13
Nystatin	Nystatin	86	22
Baclofen	Baclofen	81	16
Escitalopram Oxalate	Escitalopram Oxalate	77	19
Tradjenta	Linagliptin	75	suppressed
Donepezil Hcl	Donepezil Hcl	71	13
Divalproex Sodium	Divalproex Sodium	69	22
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	69	32
Metformin Hcl	Metformin Hcl	66	16
Pravastatin Sodium	Pravastatin Sodium	66	suppressed
Finasteride	Finasteride	63	11
Ondansetron Hcl	Ondansetron Hcl	55	27
Fluoxetine Hcl	Fluoxetine Hcl	54	15
Xifaxan	Rifaximin	54	suppressed
Hydralazine Hcl	Hydralazine Hcl	52	20
Lamotrigine	Lamotrigine	52	suppressed
Prednisone	Prednisone	52	22
Amantadine	Amantadine Hcl	47	suppressed
Amiodarone Hcl	Amiodarone Hcl	47	12
Omeprazole	Omeprazole	47	17
Duloxetine Hcl	Duloxetine Hcl	45	15
Allopurinol	Allopurinol	44	suppressed
Incruse Ellipta	Umeclidinium Bromide	44	suppressed
Latanoprost	Latanoprost	44	13
Carvedilol	Carvedilol	43	11
Myrbetriq	Mirabegron	42	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	41	20
Alendronate Sodium	Alendronate Sodium	40	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	40	26
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	14
Topiramate	Topiramate	40	suppressed
Spironolactone	Spironolactone	38	suppressed
Insulin Lispro	Insulin Lispro	36	14
Warfarin Sodium	Warfarin Sodium	36	suppressed
Memantine Hcl	Memantine Hcl	35	suppressed
Santyl	Collagenase Clostridium Hist.	35	27
Ceftriaxone	Ceftriaxone Sodium	34	22
Atenolol	Atenolol	33	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	32	25
Rytary	Carbidopa/Levodopa	32	suppressed
Risperidone	Risperidone	30	suppressed
Sodium Chloride	0.9 % Sodium Chloride	30	27
Sucralfate	Sucralfate	30	suppressed
Midodrine Hcl	Midodrine Hcl	29	suppressed
Scopolamine	Scopolamine	29	suppressed
Oxcarbazepine	Oxcarbazepine	28	suppressed
Torsemide	Torsemide	28	suppressed
Triumeq	Abacavir/Dolutegravir/Lamivudi	28	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	27	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	27	suppressed
Olanzapine	Olanzapine	27	suppressed
Enulose	Lactulose	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Metformin Hcl Er	Metformin Hcl	25	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	15
Diltiazem 24hr Er	Diltiazem Hcl	24	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	24	suppressed
Insulin Aspart Flexpen	Insulin Aspart	24	suppressed
Simvastatin	Simvastatin	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	14
Triamcinolone Acetonide	Triamcinolone Acetonide	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	21	suppressed
Verapamil Er	Verapamil Hcl	21	suppressed
Azithromycin	Azithromycin	20	12
Cephalexin	Cephalexin	20	13
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Oxycodone Hcl	Oxycodone Hcl	20	12
Albuterol Sulfate	Albuterol Sulfate	19	12
Linzess	Linaclotide	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	19	suppressed
Budesonide Er	Budesonide	18	suppressed
Clozapine Odt	Clozapine	18	suppressed
Ozempic	Semaglutide	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Cholestyramine	Cholestyramine (With Sugar)	17	suppressed
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	17	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Lansoprazole	Lansoprazole	17	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	17	12
Nystop	Nystatin	17	suppressed
Prednisolone Acetate	Prednisolone Acetate	17	suppressed
Procrit	Epoetin Alfa	17	suppressed
Sevelamer Hcl	Sevelamer Hcl	17	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Creon	Lipase/Protease/Amylase	15	suppressed
Epogen	Epoetin Alfa	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Fluticasone Propionate	Fluticasone Propionate	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	15	suppressed
Lidocaine Hcl	Lidocaine Hcl/Pf	15	14
Montelukast Sodium	Montelukast Sodium	15	suppressed
Mycophenolate Mofetil	Mycophenolate Mofetil	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Cefdinir	Cefdinir	14	12
Fenofibrate	Fenofibrate,micronized	14	suppressed
Mesalamine	Mesalamine	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Ampicillin-Sulbactam	Ampicillin Sod/Sulbactam Sod	13	suppressed
Clobetasol Propionate	Clobetasol Propionate	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Levofloxacin	Levofloxacin	13	suppressed
Paroxetine Hcl	Paroxetine Hcl	13	suppressed
Clozapine	Clozapine	12	suppressed
Digoxin	Digoxin	12	suppressed
Fluticasone-Vilanterol	Fluticasone/Vilanterol	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Klayesta	Nystatin	12	suppressed
Naloxone Hcl	Naloxone Hcl	12	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	12	suppressed
Tramadol Hcl	Tramadol Hcl	12	suppressed
Biktarvy	Bictegrav/Emtricit/Tenofov Ala	11	suppressed
Dextrose 5%-0.45% Nacl	Dextrose 5 %-0.45 % Sod Chlord	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	11	suppressed
Nuplazid	Pimavanserin Tartrate	11	suppressed
Pyridostigmine Bromide	Pyridostigmine Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error